Improving systemic delivery of oncolytic virus by cellular carriers
Oncolytic virotherapy (OVT) is a promising option for cancer treatment. OVT involves selective oncolytic virus (OV) replication within cancer cells, which triggers anti-tumor responses and immunostimulation. Despite promising potential, OVT faces critical challenges, including insufficient tumor-spe...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-12-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/21/12/1104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|